(FILES) Vials of the AstraZeneca/Oxford Covid-19 vaccine, also called Vaxzervria, destined for housebound patients, are pictured at Stubley Medical Centre near Chesterfield, central England on April 14, 2021. British drugmaker AstraZeneca said on May 8, 2024 that it has withdrawn its Covid vaccine Vaxzervria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs. "As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines. This has led to a decline in demand for Vaxzervria, which is no longer being manufactured or supplied," an AstraZeneca spokeperson said. (Photo by OLI SCARFF / AFP) (Photo by OLI SCARFF/AFP via Getty Images)